欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0929/003
药品名称
MIRUBEDIS
活性成分
RIVAROXABAN 20.0 mg
剂型
Film-coated tablet
上市许可持有人
Medac Pharma S.r.l. Via Viggiano 90 00178 Rome Italy
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
Germany (DE)
Hestba 20 mg Filmtabletten
许可日期
2020/12/23
最近更新日期
2024/01/24
药物ATC编码
B01AF01 rivaroxaban
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
04_DE6257_6258_6259_DC Rivaroxaban Sigillata Ltd_final PAR
Date of last change:2024/09/06
Final Product Information
|
common_final_pl_6258_001__V004
Date of last change:2024/09/06
Final Product Information
|
common_final_pl_6258_002_003__V004
Date of last change:2024/09/06
Final Product Information
|
common_final_pl_6258_004__V004
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_6258_001__V004
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_6258_002_003__V004
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_6258_004__V004
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase